Yungjin Pharm Co Ltd (003520) — Capital Reinvestment Ratio
Yungjin Pharm Co Ltd (003520) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩7.00 Billion) in capital expenditures (₩2.16 Billion). See Yungjin Pharm Co Ltd (003520) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yungjin Pharm Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Yungjin Pharm Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Check total reinvestment intensity of Yungjin Pharm Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Yungjin Pharm Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Yungjin Pharm Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see market cap of Yungjin Pharm Co Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | ₩21.74 Billion | ₩21.61 Billion | ▼ -26.5% |
| 2021 | 1.35x | ₩8.37 Billion | ₩11.32 Billion | ▲ +211.1% |
| 2020 | 0.43x | ₩14.50 Billion | ₩6.30 Billion | ▼ -61.0% |
| 2019 | 1.12x | ₩9.28 Billion | ₩10.36 Billion | ▼ -69.8% |
| 2018 | 3.69x | ₩1.27 Billion | ₩4.71 Billion | ▲ +9.9% |
| 2017 | 3.36x | ₩3.15 Billion | ₩10.59 Billion | ▲ +122.8% |
| 2016 | 1.51x | ₩3.11 Billion | ₩4.69 Billion | ▼ -3.5% |
| 2015 | 1.56x | ₩8.80 Billion | ₩13.75 Billion | ▼ -14.1% |
| 2014 | 1.82x | ₩6.22 Billion | ₩11.30 Billion | ▲ +63.3% |
| 2013 | 1.11x | ₩5.95 Billion | ₩6.63 Billion | — |